Abstract:ResumenLa estimulación intermitente vagal es una técnica de neuroestimulación de reciente incorporación en el tratamiento de pacientes con epilepsia refractaria al tratamiento farmacológico convencional. Hasta el momento presente y, a pesar de algunos resultados dispares, se ha mostrado como una alternativa eficaz y segura en el tratamiento de estos pacientes. El presente trabajo de revisión pretende acercar la técnica quirúrgica de implantación, comentar las indicaciones y resultados obtenidos hasta la actual… Show more
“…This electrode is connected to a pulse generator that is implanted subcutaneously in the chest wall. This surgery is performed by a neurosurgeon and takes approximately 2 hours under general anaesthesia [24].…”
In this research, a vagus nerve stimulator has been developed and miniaturized for use in epilepsy research. The board contains all the components necessary for its operation during the standard duration of the experiments, being possible to control it once implanted and even being able to reuse it. The VNS system has been designed for rodents since the VNS devices available for human are not only too large for laboratory animals, but also too expensive. With this solution the expenditure on materials made by laboratories is greatly reduced and bioethical considerations were kept in mind. The system was validated in hamsters.
This article is part of the theme issue ‘Advanced neurotechnologies: translating innovation for health and well-being’.
“…This electrode is connected to a pulse generator that is implanted subcutaneously in the chest wall. This surgery is performed by a neurosurgeon and takes approximately 2 hours under general anaesthesia [24].…”
In this research, a vagus nerve stimulator has been developed and miniaturized for use in epilepsy research. The board contains all the components necessary for its operation during the standard duration of the experiments, being possible to control it once implanted and even being able to reuse it. The VNS system has been designed for rodents since the VNS devices available for human are not only too large for laboratory animals, but also too expensive. With this solution the expenditure on materials made by laboratories is greatly reduced and bioethical considerations were kept in mind. The system was validated in hamsters.
This article is part of the theme issue ‘Advanced neurotechnologies: translating innovation for health and well-being’.
“…Recently, the use of rufinamida has been associated with great improvement in seizure frequency, but it is not common to have patients that becoming seizure free (Wier et al, 2011). In the same way as West Syndrome, some patients may have benefit of localized cortical resection, but callosotomy or vagus nerve stimulation is frequently the only options (García-March et al, 2008;Benifla et al, 2006) with some authors reporting satisfactory response.…”
Section: Lennox-gastautmentioning
confidence: 99%
“…Optimal stimulation parameters, interval between each programming and the high limits of stimulation have yet to be determined (McLachlan, 2001). The efficacy and safety of vagus nerve stimulation has been studied in several patients, including adults and children with refractory epilepsies, with satisfactory results even in small children (Alexopoulos et al, 2006;Benifla et al, 2006;García-March et al, 2008;Elliot et al, 2009;Coykendall et al, 2010;Elliot et al, 2011). It may be indicated in patients with focal or generalized epilepsies and when associated with other methods including antiepileptic drugs, ketogenic diet and resective surgeries approximately 60% of the patients experienced at least 50% reduction in seizure frequency (Elliot et al, 2011).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.